Citations

Clear

196 citation(s) found for "Schultz, M".

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes, NRG Oncology/RTOG 9501-0234.
Divi, Vasu , Cooper, Jay S., McHugh, Jonathan B. , Bell, Diana , Suntharalingam, Mohan, Raben, David, Kim, Harold E., Spencer, Sharon A., Laramore, George E. , Trotti, Andy, Foote, Robert L. , Schultz, Christopher J. , Zhang, Qiang , Harris, Jonathan , Harari, Paul M. , Sturgis, Erich M. , Cmelak, Anthony J. , Thorstad, Wade , Le, Quynh‐Thu , Holsinger, F. Christopher

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 6011-6011

10.1200/jco.2015.33.15_suppl.6011 Get It

Patient-Reported Outcomes After Percutaneous Renal Ablation: Initial Experience
Atwell, Thomas D. , Schultz, Georgianna G., Leibovich, Bradley C. , Schmit, Grant D. , Boorjian, Stephen A. , Kurup, A. Nicholas , Thompson, R. Houston, Yost, Kathleen J. , Kurup, Anil N , Schultz, Georgianna R.

Mayo Clinic

American Journal of Roentgenology | January 8, 2019 | Volume: 212 | Issue: 3 | Pages: 672-676

10.2214/ajr.17.19463 | PMID 30620680 Get It

Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG.
Buckner, Jan C. , Pugh, Stephanie L. , Shaw, Edward G. , Barger, Geoffrey, Coons, Stephen W., Ricci, Peter E. , Bullard, Dennis E., Brown, Paul D. , Stelzer, K. , Brachman, David, Schultz, Christopher J. , Bahary, Jean-Paul , Fisher, Barbara J., Kim, Harold , Murtha, Albert , Curran, Walter J. , Gilbert, Mark R. , Suh, John H. , Mehta, Minesh P.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 2000-2000

10.1200/jco.2014.32.15_suppl.2000 Get It

Imaging and diagnostic advances for intracranial meningiomas
Huang, Raymond Y. , Fougère, Christian la , Vogelbaum, Michael A. , Wen, Patrick Y, Aldape, Kenneth , Nassiri, Farshad , Zadeh, Gelareh , Dunn, Ian F. , Au, Karolyn , Barnhartz-Sloan, Jill, Bi, Wenya Linda, Brastianos, Priscilla K. , Butowski, Nicholas , Carlotti, Carlos Gilberto , Goldbrunner, Roland , Hashizume, Rintaro , Hanemann, C. Oliver , James, David, Jenkinson, Michael D. , Jungk, Christine, Kaufman, Timothy J, Krischek, Boris , Lee, Ian , Liu, Jeff C. , Mamatjan, Yasin , Mansouri, Alireza , Mawrin, Christian , Ng, Ho‐Keung , Pirouzmand, Farhad , Poisson, Laila , Pollo, Bianca , Raleigh, David R. , Sahm, Felix , Saladino, Andrea , Schichor, Christian , Selman, Warren R., Sloan, Andrew E. , Spears, Julian , Snyder, James , Suppiah, Suganth , Tabatabai, Ghazaleh , Tatagiba, Marcos , Tirapelli, Daniela Pretti da Cunha , Tsang, Derek S. , Deimling, Andreas von , Wen, Patrick Y, Walbert, Tobias , Westphal, Manfred , Workewych, Adriana M , Mansouri, Alireza , von Deimling, Andreas , Sahm, Felix , Huang, Raymond , Lee, Ian Y , Bi, Wenya Linda , Griffith, Brent D , Kaufmann, Timothy J. , Schmidt, Nils Ole , Tonn, Joerg-Christian , Wen, Patrick Yung , Cusimano, Michael D. , DiMeco, Francesco , Drummond, Katharine Jann , Galanis, Evanthia , Giannini, Caterina , Herold‐Mende, Christel C. , Horbinski, Craig , Jungk, Christine, Lachance, Daniel Honore , McDermott, Michael , Muñoz, David G. , Noushmehr, Houtan , Perry, Arie , Santarius, Thomas , Schultz, David , Hanemann, C Oliver , Mamatjan, Yasin , Tatagiba, Marcos

Mayo Clinic

Neuro-Oncology | October 18, 2018 | Volume: 21 | Issue: Supplement_1 | Pages: i44-i61

10.1093/neuonc/noy143 | PMID 30649491 Get It

Advances in multidisciplinary therapy for meningiomas
Brastianos, Priscilla K. , Butowski, Nicholas , Chan, Jason W., Dunn, Ian F. , Goldbrunner, Roland , Ippen, Franziska M. , Mawrin, Christian , Sloan, Andrew E. , Snyder, James , Tabatabai, Ghazaleh , Tatagiba, Marcos, Wen, Patrick Y. , Aldape, Kenneth, Nassiri, Farshad , Zadeh, Gelareh , Jenkinson, Michael D. , Raleigh, David R. , Au, Karolyn , Barnhartz-Sloan, Jill, Butowski, N, Carlotti, Carlos Gilberto , Griffith, Brent, Hashizume, Rintaro , Hanemann, C. Oliver , Huang, Raymond Y. , Jungk, Christine, Kaufman, Timothy J, Krischek, Boris , Lee, Ian , Liu, Jeff C. , Mamatjan, Yasin , Mansouri, Alireza , Ng, Ho‐Keung , Pirouzmand, Farhad , Poisson, Laila , Pollo, Bianca , Sahm, Felix , Saladino, Andrea , Santarius, Thomas , Schichor, Christian , Selman, Warren R., Spears, Julian , Suppiah, Suganth , Tatagiba, Marcos, Tirapelli, Daniela, Tsang, Derek S. , Vogelbaum, Michael A. , Deimling, Andreas von , Walbert, Tobias , Westphal, Manfred , Workewych, Adriana M , Tatagiba, Marcos , Galanis, Evanthia , Mansouri, Alireza , von Deimling, Andreas , Sahm, Felix , Huang, Raymond , Lee, Ian Y , Herold‐Mende, Christel C. , McDermott, Michael , Tatagiba, Marcos , Tonn, Joerg-Christian , Wen, Patrick Yung , Bi, Wenya Linda , Cusimano, Michael D. , DiMeco, Francesco , Drummond, Katharine Jann , Giannini, Caterina , Horbinski, Craig , James, David, Jungk, Christine, Lachance, Daniel Honore , Fougère, Christian la , Muñoz, David G. , Noushmehr, Houtan , Perry, Arie , Schultz, David , Schmidt, Nils Ole , Hanemann, C Oliver , Mamatjan, Yasin

Mayo Clinic

Neuro-Oncology | September 17, 2018 | Volume: 21 | Issue: Supplement_1 | Pages: i18-i31

10.1093/neuonc/noy136 | PMID 30649489 Get It

Use of revised International Prognostic Scoring System (IPSS-R) in hypocellular myelodysplastic syndromes (MDS): Mayo Clinic experience.
Cerquozzi, Sonia , Zblewski, Darci, Begna, Kebede H. , Schultz, Kirsten, Litzow, Mark R. , Al‐Kali, Aref , Alkhateeb, Hassan B. , Chen, Dong

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7063-7063

10.1200/jco.2016.34.15_suppl.7063 Get It

International multicenter observational study on assessment of ventilatory management during general anaesthesia for robotic surgery and its effects on postoperative pulmonary complication (AVATaR): study protocol and statistical analysis plan
Queiroz, Verônica Neves Fialho , Barbosa, Rogerio Póvoa, Takaoka, Flávio , Baerdemaeker, Luc De , Cesar, Daniel Souza, D’Orto, Ulisses Cardoso, Galdi, José Roberto, Hemmes, Sabrine N.T. , Hollman, Markus W, Kalmar, Alain F. , Moura, Lucas A B de, Mariano, Renato, Matot, Idit , Mazzinari, Guido , Mills, Gary , Posso, Irimar de Paula, Teruya, Alexandre , Melo, Marcos Francisco Vidal, Treschan, Tanja A. , Eidelman, Leonid A., Chen, Lee‐lynn , Lee, Jae Woo , Irujo, J.J. Ariño, Tena, Beatriz , Groeben, Harald , Pelosi, Paolo , Schultz, Marcus J. , Costa, Luiz Guilherme Villares da , Cesar, Daniel Souza, Gottumukkala, Vijaya N. R. , Cata, Juan P. , Moura, Lucas Araújo de Borges , Šprung, Juraj , Weingarten, Toby N. , Koopman, Seppe , Abreu, Marcelo Gama de , Neto, Ary Serpa , Schultz, Marcus J

Mayo Clinic

BMJ Open | August 23, 2018 | Volume: 8 | Issue: 8 | Pages: e021643

10.1136/bmjopen-2018-021643 | PMID 30139899 Get It

Introduction Robotic-assisted surgery (RAS) has emerged as an alternative minimally invasive surgical option. Despite its growing applicability, the frequent need for pneumoperitoneum and Trendelenburg position could significantly affect respiratory mechanics during RAS. AVATaR is an international multicenter observational study aiming to assess the incidence of postoperative pulmonary complications (PPC), to characterise current practices of mechanical ventilation (MV) and to evaluate a possible association between ventilatory parameters and PPC in patients undergoing RAS. Methods and analysis AVATaR is an observational study of surgical patients undergoing MV for general anaesthesia for RAS. The primary outcome is the incidence of PPC during the first five postoperative days. Secondary outcomes include practice of MV, effect of surgical positioning on MV, effect of MV on clinical outcome and intraoperative complications. Ethics and dissemination This study was approved by the Institutional Review Board of the Hospital Israelita Albert Einstein. The study results will be published in peer-reviewed journals and disseminated at international conferences. Trial registration number NCT02989415 ; Pre-results.
Abstract 2334: Sialylation of the TNFR1 death receptor promotes cancer cell survival
Holdbrooks, Andrew T., Liu, Zhongyu , Bullard, Daniel C. , Schultz, Matthew , Bellis, Susan L.

Mayo Clinic

Cancer Research | August 17, 2018 | Volume: 78 | Issue: 13_Supplement | Pages: 2334-2334

10.1158/1538-7445.am2018-2334 Get It

Abstract Studies have well-established that activation of TNFR1, a ubiquitously expressed cell surface receptor, by TNF can induce either cell survival or cell death signaling cascades, however, the mechanisms regulating TNFR1 to initiate these disparate outcomes are poorly understood. TNF-induced apoptosis is initiated by clustering of activated TNFR1 at the cell surface, followed by internalization of the receptor complexes and subsequent caspase activation. Conversely, surface retention of activated TNFR1 promotes cell survival signaling mediated by NFκB and MAPKs pathways. Our group has identified a glycosylation-dependent mechanism that controls this TNFR1 signaling switch (i.e. apoptosis vs. survival). Specifically, we have found that TNFR1 activity is modified by the addition of a distinct sugar, an α2-6 linked sialic acid, by the Golgi sialyltransferase, ST6Gal-I. Importantly, ST6Gal-I is highly upregulated in numerous cancer types, and through its sialylation of a select cohort of cell surface receptors, various studies have indicated ST6Gal-I as a potent tumor cell survival factor. The effect of sialylation on TNFR1 was examined in multiple cancer cell models, including leukemia and epithelial cancer cell lines with forced overexpression or knockdown of ST6Gal-I. These models show that TNFR1 sialylation blocks TNF-induced apoptosis (indicated by the inhibition of caspase activation), and data from our group suggests that the underlying mechanism of this inhibition of apoptosis involves the sialylation-driven interference of TNFR1 oligomerization and internalization. Considering sialylated TNFR1 is retained on the cell surface following activation, we hypothesize that cells with abundant ST6Gal-I not only block TNFR1-mediated apoptosis but also divert signaling towards survival, indicated by increased activity and expression of many pro-survival factors (NFkB, AKT, etc.). Based on these collective findings, we conclude that the ST6Gal-I-mediated sialylation of TNFR1 controls the cellular response to TNF by blocking TNFR1 internalization, resulting in apoptosis inhibition and the promotion of survival signaling. Considering the tumor microenvironment is rich in immune cell-derived TNF, we posit that ST6Gal-I protects tumor cells within this inflammatory milieu by providing a mechanism by which tumor cells can evade immune cell killing. Citation Format: Andrew T. Holdbrooks, Matthew J. Schultz, Zhongyu Liu, Daniel C. Bullard, Susan L. Bellis. Sialylation of the TNFR1 death receptor promotes cancer cell survival [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 2334.